Is there a causal link between psychological disorders and functional gastrointestinal disorders?

References

• Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002;97(9):2290–2299.
   PubMed Web of Science ®Google Scholar
• Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012 July 1;10(7):712–721.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Hasler WL. Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016 May 1;150(6):1257–1261.
   PubMed Web of Science ®Google Scholar
• Morris-Yates A, Talley NJ, Boyce PM, et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998;93(8):1311–1317.
   PubMed Web of Science ®Google Scholar
• Sinagra E, Pompei G, Tomasello G, et al. Inflammation in irritable bowel syndrome: myth or new treatment target? World J Gastroenterol. 2016 Feb 21;22(7):2242.
   PubMed Web of Science ®Google Scholar
• Walker MM, Aggarwal KR, Shim LS, et al. Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort. J Gastroenterol Hepatol. 2014 Mar;29(3):474–479.
   PubMed Web of Science ®Google Scholar
• Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009 Apr;29(7):765–773.
   PubMed Web of Science ®Google Scholar
• Saffouri GB, Shields-Cutler RR, Chen J, et al. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nat Commun. 2019 May 1;10(1):1.
   PubMedGoogle Scholar
• Koloski NA, Jones M, Kalantar J, et al. The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012 Sept 1;61(9):1284–1290.
   PubMed Web of Science ®Google Scholar
• Talley NJ. What causes functional gastrointestinal disorders? A proposed disease model. Am J Gastroenterol. 2020 Jan 1;115(1):41–48.
   PubMed Web of Science ®Google Scholar
• Holtmann G, Shah A, Morrison M. Pathophysiology of functional gastrointestinal disorders: a holistic overview. Dig Dis. 2017;35(S1):5–13.
   PubMedGoogle Scholar
• Talley NJ. Scope of the problem of functional digestive disorders. Eur J Surg. 1998 Dec;164(S12):35–41.
   PubMedGoogle Scholar
• Poulsen CH, Eplov LF, Hjorthøj C, et al. Irritable bowel symptoms, use of healthcare, costs, sickness and disability pension benefits: a long-term population-based study. Scand J Public Health. 2019 Dec;47(8):867–875.
   PubMed Web of Science ®Google Scholar
• Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol. 2000 Jan 1;95(1):67–71.
   PubMed Web of Science ®Google Scholar
• Choi MG, Jung HK. Health related quality of life in functional gastrointestinal disorders in Asia. J Neurogastroenterol Motil. 2011 July;17(3):245.
   PubMed Web of Science ®Google Scholar
• Fond G, Loundou A, Hamdani N, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014;264:651–660.
   PubMed Web of Science ®Google Scholar
• Lee C, Doo E, Choi JM, et al. The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis. J Neurogastroenterol Motil. 2017;23:349–362.
   PubMed Web of Science ®Google Scholar
• Zhang Q-E, Wang F, Geng Q, et al. Depressive symptoms in patients with irritable bowel syndrome: a meta-analysis of comparative studies. Int J Biol Sci. 2018;14:1504–1512.
   PubMed Web of Science ®Google Scholar
• Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019 July;50(2):132–143.
   PubMed Web of Science ®Google Scholar
• Hausteiner-Wiehle C, Henningsen P. Irritable bowel syndrome: relations with functional, mental, and somatoform disorders. World J Gastroenterol. 2014;20:6024–6030.
   PubMed Web of Science ®Google Scholar
• Farzaneh N, Ghobakhlou M, Moghimi-Dehkordi B, et al. Evaluation of psychological aspects among subtypes of irritable bowel syndrome. Indian J Psychol Med. 2012;234:144–148.
   Google Scholar
• Walker EA, Katon WJ, Jemelka RP, et al. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. Am J Med. 1992;92:26S–30S.
   PubMed Web of Science ®Google Scholar
• Boyce PM, Talley NJ, Burke C, et al. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Intern Med J. 2006 Jan;36(1):28–36.
   PubMed Web of Science ®Google Scholar
• Mykletun A, Jacka F, Williams L, et al. Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women. BMC Gastroenterol. 2010 Dec 1;10(1):88.
   PubMedGoogle Scholar
• Lee S, Wu J, Ma YL, et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther. 2009 Sept;30(6):643–651.
   PubMed Web of Science ®Google Scholar
• Koloski N, Jones M, Walker MM, et al. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther. 2019 Mar;49(5):546–555.
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Bosmajian L, Zonderman AB, et al. Symptoms of psychologic distress associated with irritable bowel syndrome: comparison of community and medical clinic samples. Gastroenterology. 1988 Sept 1;95(3):709–714.
   PubMed Web of Science ®Google Scholar
• Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988 Sept 1;95(3):701–708.
   PubMed Web of Science ®Google Scholar
• Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295.
   PubMed Web of Science ®Google Scholar
• Koloski NA, Jones M, Talley NJ. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study. Aliment Pharmacol Ther. 2016 Sep;44(6):592–600.
   PubMed Web of Science ®Google Scholar
• Aro P, Talley NJ, Johansson SE, et al. Anxiety is linked to new-onset dyspepsia in the Swedish population: a 10-year follow-up study. Gastroenterology. Gastroenterology. 2009 July 1;137(1):94–100.
   PubMed Web of Science ®Google Scholar
• Sykes M, Blanchard E, Lackner J, et al. Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med. 2003;26:361–372.
   PubMed Web of Science ®Google Scholar
• Jones MP, Tack J, Van Oudenhove L, et al. Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population. Clin Gastroenterol Hepatol. 2017 July 1;15(7):1014–1020.
   PubMed Web of Science ®Google Scholar
• Sibelli A, Chalder T, Everitt H, et al. A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychol Med. 2016 Nov;46(15):3065–3080.
   PubMed Web of Science ®Google Scholar
• Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet. 1996;347:150–153.
   PubMed Web of Science ®Google Scholar
• Borgaonkar MR, Ford DC, Marshall JK, et al. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci. 2006;51:1026–1032.
   PubMed Web of Science ®Google Scholar
• Nielsen HL, Engberg J, Ejlertsen T, et al. Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection. Scand J Gastroenterol. 2014;49:545–551.
   PubMed Web of Science ®Google Scholar
• Nicholl B, Halder S, Macfarlane G, et al. Psychosocial risk markers for new onset irritable bowel syndrome – results of a large prospective population-based study. Pain. 2008;137:147–155.
   PubMed Web of Science ®Google Scholar
• Moss-Morris R, Spence M. To “lump” or to “split” the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med. 2006 May 1;68(3):463–469.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol. 2001;96:1072–1079.
   PubMed Web of Science ®Google Scholar
• Wouters MM, Van Wanrooy S, Nguyen A, et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut. 2015;65:1279–1288.
   PubMed Web of Science ®Google Scholar
• Marshall JK, Thabane M, Garg AX, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59:605–611.
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651–1659.
   PubMed Web of Science ®Google Scholar
• Schwille-Kiuntke J, Enck P, Zendler C, et al. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil. 2011;23:e479–88.
   PubMed Web of Science ®Google Scholar
• Parry SD, Barton JR, Welfare MR. Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? Eur J Gastroenterol Hepatol. 2005 Oct 1;17(10):1071–1075.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Sarkhel S, Sarkar R, et al. Anxiety and depression in irritable bowel syndrome. Indian J Psychol Med. 2017 Nov;39(6):741.
   PubMedGoogle Scholar
• Drossman DA. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med. 1999 Nov 8;107(5):41–50.
   Google Scholar
• Kanuri N, Cassell B, Bruce SE, et al. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS). Neurogastroenterol Motility. 2016 Oct;28(10):1508–1517.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Fett SL, Zinsmeister AR, et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology. 1994 Oct 1;107(4):1040–1049.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut. 1998 Jan 1;42(1):47–53.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Chang L, Bellamy N, et al. Severity in irritable bowel syndrome: a rome foundation working team report. Am J Gastroenterol. 2011;106(10):1749–59; quiz 1760.
   Web of Science ®Google Scholar
• Laird KT, Tanner-Smith EE, Russell AC, et al. Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 2016 Jul 1;14(7):937-947.
   Google Scholar
• Ford AC, Talley NJ, Schoenfeld PS, et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009 Mar 1;58(3):367–378.
   PubMed Web of Science ®Google Scholar
• Altayar O, Sharma V, Prokop LJ, et al. Psychological therapies in patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Gastroenterol Res Pract. 2015;2015:1–19.
   PubMedGoogle Scholar
• Lackner JM, Mesmer C, Morley S, et al. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol. 2004 Dec;72(6):1100.
   PubMed Web of Science ®Google Scholar
• Henrich JF, Knittle K, De Gucht V, et al. Identifying effective techniques within psychological treatments for irritable bowel syndrome: a meta-analysis. J Psychosom Res. 2015 Mar 1;78(3):205–222.
   PubMed Web of Science ®Google Scholar
• Popa SL, Chiarioni G, David L, et al. The efficacy of hypnotherapy in the treatment of functional dyspepsia. Am J Ther. 2019 Nov 1;26(6):e704–13.
   PubMed Web of Science ®Google Scholar
• Hojo M, Nagahara A, Asaoka D, et al. A systematic review of the effectiveness of antianxiety and antidepressive agents for functional dyspepsia. Int Med. 2017 Dec 1;56(23):3127–3133.
   PubMed Web of Science ®Google Scholar
• Lu Y, Chen M, Huang Z, et al. Antidepressants in the treatment of functional dyspepsia: a systematic review and meta-analysis. PloS One. 2016 June 16;11(6):e0157798.
   PubMed Web of Science ®Google Scholar
• Windgassen S, Moss-Morris R, Chilcot J, et al. The journey between brain and gut: a systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome. Br J Health Psychol. 2017 Nov;22(4):701–736.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Kanazawa M, Fukudo S, et al. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011 Apr;17(2):131.
   PubMed Web of Science ®Google Scholar
• Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011 Feb;18(62):381–396.
   Google Scholar
• Carabotti M, Scirocco A, Maselli MA, et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015 Apr;28(2):203.
   PubMed Web of Science ®Google Scholar
• Stasi C, Rosselli M, Bellini M, et al. Altered neuro-endocrine–immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.. J Gastroenterol. 2012 Nov 1;47(11):1177–1185.
   PubMed Web of Science ®Google Scholar
• Dinan TG, Quigley EM, Ahmed SM, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology. 2006;130:304–311.
   PubMed Web of Science ®Google Scholar
• Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998;42:845–849.
   PubMed Web of Science ®Google Scholar
• Heitkemper M, Burr RL, Jarrett M, et al. Evidence for autonomic nervous system imbalance in women with irritable bowel syndrome. Dig Dis Sci. 1998;43:2093–2098.
   PubMed Web of Science ®Google Scholar
• Kennedy PJ, Clarke G, Quigley EM, et al. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36:310–340.
   PubMed Web of Science ®Google Scholar
• Posserud I, Agerforz P, Ekman R, et al. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut. 2004;53:1102–1108.doi:10.1136/gut.2003.017962
   PubMed Web of Science ®Google Scholar
• Bohmelt AH, Nater UM, Franke S, et al. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med. 2005;67:288–294.
   PubMed Web of Science ®Google Scholar
• Kennedy PJ, Quigley E, Cryan JF, et al. A sustained hypothalamic-pituitary-adrenal axis response to acute psychosocial stress in irritable bowel syndrome. Psychol Med. 2014;44:3123–3134.
   Web of Science ®Google Scholar
• Bengtson MB, Ronning T, Vatn MH, et al. Irritable bowel syndrome in twins: genes and environment. Gut. 2006;55(12):1754–1759.
   PubMed Web of Science ®Google Scholar
• Bengtson MB, Aamodt G, Vatn MH, et al. Co-occurrence of IBS and symptoms of anxiety or depression, among Norwegian twins, is influenced by both heredity and intrauterine growth. BMC Gastroenterol. 2015 Dec 1;15(1):9.
   PubMed Web of Science ®Google Scholar
• Wojczynski MK, North KE, Pedersen NL, et al. Irritable bowel syndrome: a co-twin control analysis. Am J Gastroenterol. 2007;102(10):2220–2229.
   PubMed Web of Science ®Google Scholar
• Jarrett ME, Kohen R, Cain KC, et al. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs. 2007;9:161–169.
   PubMed Web of Science ®Google Scholar
• Fukudo S, Kanazawa M, Mizuno T, et al. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage. 2009;47:946–951.
   PubMed Web of Science ®Google Scholar
• Senese NB, Rasenick MM, Traynor JR. The role of G-proteins and G-protein regulating proteins in depressive disorders. Front Pharmacol. 2018 Nov 13;(9):1289. DOI:10.3389/fphar.2018.01289
   PubMedGoogle Scholar
• Holtmann G, Siffert W, Haag S, et al. G-protein ß3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology. 2004 Apr 1;126(4):971–979.
   PubMed Web of Science ®Google Scholar
• Jiang D, Huang D, Cai W, et al. G protein beta 3 (GNß3) C825T polymorphism and irritable bowel syndrome susceptibility: an updated meta-analysis based on eleven case-control studies. Oncotarget. 2018 Jan 5;9(2):2770.
   PubMedGoogle Scholar
• Pittayanon R, Lau JT, Yuan Y, et al. Gut microbiota in patients with irritable bowel syndrome-a systematic review. Gastroenterology. 2019;157:97–108.
   PubMed Web of Science ®Google Scholar
• Liu HN, Wu H, Chen YZ, et al. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis. Dis Liver Dis. 2017;49:331–337.
   PubMedGoogle Scholar
• Simpson CA, Mu A, Haslam N, et al. Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome. J Affect Disord. 2020;266:429–446.
   Web of Science ®Google Scholar
• Jiang HY, Zhang X, Yu ZH, et al. Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res. 2018;104:130–136.
   PubMed Web of Science ®Google Scholar
• Peter J, Fournier C, Durdevic M, et al. Moser G. A microbial signature of psychological distress in irritable bowel syndrome. Psychosom Med. 2018 Oct;80(8):698.
   PubMed Web of Science ®Google Scholar
• Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017 Aug 1;153(2):448–459.
   PubMed Web of Science ®Google Scholar
• Kurokawa S, Kishimoto T, Mizuno S, et al. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study. J Affect Disord. 2018 Aug;1(235):506–512.
   Google Scholar
• Peter J, Fournier C, Keip B, et al. Intestinal microbiome in irritable bowel syndrome before and after gut-directed hypnotherapy. Int J Mol Sci. 2018 Nov;19(11):3619.
   Web of Science ®Google Scholar
• Mayer EA, Savidge T, Shulman RJ. Brain–gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014 May 1;146(6):1500–1512.
   PubMed Web of Science ®Google Scholar
• Gray MA, Chao CY, Staudacher HM, et al. Anti-TNFa therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases. PloS One. 2018;13(3). DOI:10.1371/journal.pone.0193542
   Web of Science ®Google Scholar
• Feng B, La JH, Schwartz ES, et al. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J Physiol. 2012;302(10):G1085–G1098.
   PubMed Web of Science ®Google Scholar
• Lambert GP. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J Anim Sci. 2009;87((14)(Suppl.)):E101–E108.
   PubMed Web of Science ®Google Scholar
• Philpott H, Gibson P, Thien F. Irritable bowel syndrome - An inflammatory disease involving mast cells. Asia Pac Allergy. 2011;1:36–42.
   PubMedGoogle Scholar
• Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 2008 Apr 1;57(4):468–473.
   PubMed Web of Science ®Google Scholar
• Eutamene H, Theodorou V, Fioramonti J, et al. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats. Journal of Physiology. 2003 Dec;553(3):959–966.
   PubMed Web of Science ®Google Scholar
• Santos J, Saperas E, Nogueiras C, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology. 1998 Apr 1;114(4):640–648.
   PubMed Web of Science ®Google Scholar
• Wouters MM, Balemans D, Van Wanrooy S, et al. Histamine receptor H1–mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome. Gastroenterology. 2016 Apr 1;150(4):875–887.
   PubMed Web of Science ®Google Scholar
• Matricon J, Muller E, Accarie A, et al. Peripheral contribution of NGF and ASIC1a to colonic hypersensitivity in a rat model of irritable bowel syndrome. Neurogastroenterol Motil. 2013;25:e740–e754.
   PubMed Web of Science ®Google Scholar
• Berry A, Bindocci E, Alleva E. NGF, brain and behavioral plasticity. Neural Plast. 2012;2012:784040.
   PubMed Web of Science ®Google Scholar
• Yu YB, Zuo XL, Zhao QJ, et al. Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut. 2012;61:685–694.
   PubMed Web of Science ®Google Scholar
• Frielingsdorf H, Bath KG, Soliman F, et al. Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder. Ann N Y Acad Sci. 2011;1208:150–157.
   Web of Science ®Google Scholar
• Scully P, McKernan DP, Keohane J, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol. 2010;105:2235–2243.
   PubMed Web of Science ®Google Scholar
• Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007 Mar 1;132(3):913–920.
   PubMed Web of Science ®Google Scholar
• Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med. 2013;6:93–96.
   PubMed Web of Science ®Google Scholar
• Jones MP, Chey WD, Singh S, et al. A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther. 2014 Feb;39(4):426–437.
   PubMed Web of Science ®Google Scholar
• Fairlie T, Bray N, Chao J, et al. Is there an association between improvement of GI symptoms in patients with functional gastrointestinal disorders and alterations of circulating gut homing T cells and pro-inflammatory cytokines in response to a 12 week multidisciplinary treatment approach? Gastroenterology. 2020. Accepted Abstract.
   Google Scholar
• Wang D, Zhang X, Zhang X, et al. Magnetic resonance imaging analysis of brain function in patients with irritable bowel syndrome. BMC Gastroenterol. 2017 Dec 1;17(1):148.
   PubMedGoogle Scholar
• Posserud I, Ersryd A, Simren M. Functional findings in irritable bowel syndrome. World J Gastroenterol. 2006;12(18):2830–2838.
   PubMed Web of Science ®Google Scholar
• Qi R, Liu C, Ke J, et al. Intrinsic brain abnormalities in irritable bowel syndrome and effect of anxiety and depression. Brain Imaging Behav. 2016 Dec 1;10(4):1127–1134.
   PubMed Web of Science ®Google Scholar
• Liu P, Wang G, Liu Y, et al. Disrupted intrinsic connectivity of the periaqueductal gray in patients with functional dyspepsia: a resting-state fMRI study. Neurogastroenterol Motility. 2017 Aug;29(8):e13060.
   Web of Science ®Google Scholar